Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Fried, J. L., Arbuckle, M. R., Weinberg, M., Carino, A., McQuistion, H. L., Shoyinka, S. O., . . .Stern, D. A. (2014). Psychiatry residents' experiences with systems-based practice: A qualitative survey. Academic Psychiatry, 38(4), 414-419. doi:10.1007/s40596-014-0038-6
Friedlander, S. L., Tichenor, W. S., & Skoner, D. P. (2013). Risk of adverse effects, misdiagnosis, and suboptimal patient care with the use of over-the-counter triamcinolone. Annals of Allergy Asthma & Immunology, 111(5), 319-322. doi:10.1016/j.anai.2013.09.013
Friedman, D. J., Al-Khatib, S. M., Zeitler, E. P., Han, J., Bardy, G. H., Poole, J. E., . . . Kadish, A. H. (2017). New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. American Heart Journal, 191, 21-29. This material can be found here.
Friedman, D. M., Domachowske, J. B., Wong, P. C., Parimi, P. S., Garcia, D. F., Marcus, M. G., . . . Kumar, V. R. (2016). Perceived risk of severe respiratory syncytial virus disease and immunoprophylaxis use among US pediatric specialists. Clinical Pediatrics, 55(8), 724-737. doi:10.1177/0009922815604598
Friedman, E., & Billick, S. (2015). Unintentional child neglect: Literature review and observational study. Psychiatric Quarterly, 86(2), 253-260. doi:10.1007/s11126-014-9328-0
Friedman, H., & Cohn, G. M. (2002). Improving employer-employee relationships: A Biblical and Talmudic perspective on human resource management. Management Decision, 40(10), 955-961. This material can be found here.
Friedman, L. K., & Hu, S. (2014). Early-life seizures in predisposing neuronal preconditioning: a critical review. Life Sciences, 94(1), 92-98. doi:10.1016/j.lfs.2013.11.003
Friedman, L. K., Goldstein, B., Rafiuddin, A., Roblejo, P., & Friedman, S. (2013). Lack of resveratrol neuroprotection in developing rats treated with kainic acid. Neuroscience, 230, 39-49. doi:10.1016/j.neuroscience.2012.10.063, PMID: 23159308
Friedman, L. K., Mancuso, J., Patel, A., Kudur, V., Leheste, J. R., Iacobas, S., . . . Spray, D. C. (2013). Transcriptome profiling of hippocampal CA1 after early-life seizure-induced preconditioning may elucidate new genetic therapies for epilepsy. European Journal of Neuroscience, 38(1), 2139-52. doi:10.1111/ejn.12168
Friedman, L. K., Sharma, A., Corcia, M., Webster, T., Qazi, L., Simsovits, D., . . . Hong, H. (2016). Selective inhibition of metabotropic glutamate type 1 alpha receptor (mGluR1alpha) reduces cell proliferation and migration following status epilepticus in early development. International Journal of Developmental Neuroscience, 54, 6-21. doi:10.1016/j.ijdevneu.2016.08.002
Friedman, L. K., Slomko, A. M., Wongvravit, J. P., Naseer, Z., Hu, S., Wan, W. Y., & Ali, S. S. (2015). Efficacy of retigabine on acute limbic seizures in adult rats. Journal of Epilepsy Research, 5(2), 46-59. doi:10.14581/jer.15010
Friedman, M. D., Jeevan, D. S., Tobias, M., Murali, R., & Jhanwar-Uniyal, M. (2013). Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid. Oncology Reports, 30(4), 1645-1650. doi:10.3892/or.2013.2625
Friedman, M. L., Peyko, V., Todorov, D., Burney, S., Brooks, S., & Cohen, H. (2015). Role of antifungal therapy in the treatment of persistent diarrhea in hospitalized patients. Journal of Pharmacy Practice, 28(3), 302-303. doi:10.1177/0897190015583953
Friedman, O. (2009). On real and Jordan Lassner algebras and Gelfand-Naimark type theorems for barreled real locally C*- and locally JB-algebras. Indian Journal of Mathematics, 51, 111-132
Friedman, R. C., Downey, J., Alfonso, C., Igram, D. (2013). What is "psychodyanamic psychiatry"? Psychodyamic Psychiatry, 41(4), 511-512. Ingram, D. H., Alfonso, C." href="http://dx.doi.org/10.1521/pdps.2013.41.4.511" target="_blank">doi: 10.1521/pdps.2013.41.4.511
Friedman, T. M., Jones, S. C., Statton, D., Murphy, G. F., & Korngold, R. (2004). Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens. Biology of Blood and Marrow Transplantion, 10(4), 224-235. This material can be found here.
Friedman, T. M., Statton, D., Jones, S. C., Berger, M. A., Murphy, G. F., & Korngold, R. (2001). Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate. Biology of Blood and Marrow Transplantion, 7(1), 2-13. This material can be found here.
Frishman, W. H. (2013). Cardiac disease. In P. Boyle, P. Boffetta, A. B. Lowenfels, H. Burns, O. Brawley, W. Zatonski, & J. Rehm (Eds.), Alcohol: Science, policy, and public health (pp. 249-255). Oxford, England: Oxford University Press.
Frishman, W. H. (2013). β-Adrenergic blockade in cardiovascular disease. Journal of Cardiovascular Pharmacology and Therapeutics, 18(4), 310-319. doi:10.1177/1074248413484986
Frishman, W. H. (2015). Can clinicians improve on the effectiveness of statins with additional lipid-lowering therapies? The American Journal of Medicine, 128(11), 1160-1161. doi:10.1016/j.amjmed.2015.06.027
Frishman, W. H. (2015). Is the stethoscope becoming an outdated diagnostic tool? The American Journal of Medicine, 128(7), 668-669. doi:10.1016/j.amjmed.2015.01.042
Frishman, W. H. (2015). Pharmacists in primary care. The American Journal of Medicine, 128(5), 443-444. doi:10.1016/j.amjmed.2014.11.021
Frishman, W. H. (2016). Beta-adrenergic receptor blockers in hypertension: Alive and well. Progress in Cardiovascular Diseases, 59(3), 247-252. doi:10.1016/j.pcad.2016.10.005
Frishman, W. H. (2016). Reflections on the Physicians Payment Sunshine Act. The American Journal of Medicine, 129(1), 3-4. doi:10.1016/j.amjmed.2015.08.001
Frishman, W. H. (2016). The reply. The American Journal of Medicine, 129(9), e203. doi:10.1016/j.amjmed.2016.02.051
